Mephedrone

Price range: $450.00 through $8,700.00

WeightPrice
100 g$450.00
200 g$670.00
300 g$810.00
400 g$900.00
500 g$960.00
600 g$1,090.00
700 g$1,215.00
800 g$1,345.00
900 g$1,470.00
1000 g$1,600.00
2000 g$2,390.00
3000 g$3,180.00
5000 g$4,755.00
10000 g$8,700.00
SKU: Mephedrone Category:

Mephedrone, also known as 4-methylmethcathinone (4-MMC) or 4-methylcathinone, is a synthetic cathinone with stimulant and entactogenic effects. It is structurally related to methcathinone and MDMA and became widely known in Europe in the late 2000s as a recreational stimulant. Unlike many newer cathinones, mephedrone has been studied in controlled human experiments, and its acute effects include euphoria, increased sociability and marked cardiovascular stimulation.

History and chemistry

Mephedrone is a ring-substituted methcathinone with a methyl group at the para position of the phenyl ring. It is a beta-keto analogue of 4-methylamphetamine and has a chiral centre, so it exists as R- and S-enantiomers.

The compound was reported in online drug markets in the mid-2000s and became increasingly popular in Europe in 2009–2010. It was often sold as a legal alternative to MDMA or cocaine. Several countries introduced controls in 2010, followed by international scheduling in 2015.

Pharmacology

Mephedrone acts as a substrate-type releaser at dopamine, norepinephrine and serotonin transporters. It enters nerve terminals through these transporters and promotes the release of monoamine neurotransmitters. This mechanism is broadly similar to MDMA, although the relative effects on dopamine and serotonin differ.

In a controlled human study, mephedrone produced stimulant-like effects, euphoria and well-being, alongside increases in blood pressure, heart rate and pupil diameter. Its subjective effects resembled those of MDMA but peaked earlier and were shorter lived. The trial involved twelve male volunteers in a randomised, double-blind, placebo-controlled crossover design (Papaseit and colleagues, 2016).

Subjective effects

The PsychonautWiki profile of mephedrone describes stimulation, euphoria and entactogenic effects. Users often draw comparisons with MDMA, while emphasising the shorter duration and tendency towards repeated use.

Physical effects

Stimulation and increased energy are common. Users report a warm or tingling bodily sensation, tactile enhancement and increased physical activity. Jaw clenching, sweating, increased heart rate, elevated blood pressure, dry mouth and reduced appetite are also described. Some people experience nausea, headaches or difficulty sleeping.

Emotional and cognitive effects

Euphoria, empathy, sociability and emotional openness are recurring features. Some users report increased appreciation of music and a stronger desire to interact with others. Faster thoughts and disinhibition may accompany these effects.

Anxiety, agitation, irritability and paranoia can occur, particularly during prolonged use. The short-lived nature of the desired effects is often associated with repeated redosing in user reports.

Clinical toxicity

Clinical reports describe tachycardia, hypertension, chest pain, agitation, hyperthermia, seizures and psychiatric disturbances. Severe cases have included cardiovascular collapse and death. Many clinical reports involve more than one drug, making it difficult to isolate mephedrone’s contribution.

A systematic review of human studies found evidence of stimulant and rewarding effects, while noting that the clinical literature includes both acute toxicity and patterns of compulsive use (Abdullah and colleagues, 2022).

Dependence and longer-term effects

Repeated use has been associated with craving, tolerance-like patterns and difficulty controlling intake. Animal studies have investigated changes in monoamine systems after repeated exposure, but the extent of persistent neurotoxicity in humans remains uncertain. A review of the neurotoxicological literature highlights differences between animal models and human observations, and cautions against treating all reported cognitive or psychiatric symptoms as evidence of permanent neuronal damage (Pantano and colleagues, 2017).

Related compounds

Mephedrone is related to Methcathinone, 3-MMC, 4-MEC and 3,4-DMMC. It is the para-methyl positional isomer of 3-MMC and a close structural relative of other ring-substituted methcathinones.

Weight

100 g, 200 g, 300 g, 400 g, 500 g, 600 g, 700 g, 800 g, 900 g, 1000 g, 2000 g, 3000 g, 5000 g, 10000 g

Identity and Structure

Chemical NameMephedrone
Catalog Entity TypeCompound
FormulaC11H15NO
Molar Mass177.247 g·mol−1
CAS1189805-46-6
1189726-22-4
CAS Numbers and Substance Forms1189805-46-6
1189726-22-4 (HCl)
Synonyms4-Methyl-N-methylcathinone; 2-Methylamino-1-p-tolylpropan-1-one
IUPAC Name(RS)-2-Methylamino-1-(4-methylphenyl)propan-1-one
InChIInChI=1S/C11H15NO/c1-8-4-6-10(7-5-8)11(13)9(2)12-3/h4-7,9,12H,1-3H3
InChIKeyYELGFTGWJGBAQU-UHFFFAOYSA-N
SMILESCC1=CC=C(C(C(NC)C)=O)C=C1

Chemical Identifiers

PubChem CID29982893
ChemSpider ID21485694
DrugBank IDDB13108
ChEBI IDCHEBI:59331
KEGG IDC22785
UNII8BA8T27317
CompTox DTXSIDDTXSID20891437
ECHA ID100.189.720

Clinical Data

Drug ClassSerotonin–norepinephrine–dopamine releasing agent; Serotonin–norepinephrine–dopamine reuptake inhibitor; Stimulant; Entactogen; Euphoriant; Sympathomimetic
Pronunciation/ˈmɛfədroʊn/
Routes of AdministrationOral, insufflation, IV, rectal
ATC CodeNone

Pharmacokinetics

Metabolites4-Methylephedrine

Legal Status

Legal Status (Wikipedia Source Text)AU: S9 (Prohibited substance)
BR: Class F2 (Prohibited psychotropics)
DE: Anlage I (Authorized scientific use only)
UK: Class B
US: Schedule I
UN: Psychotropic Schedule II

Sources and Attribution

Wikipedia Source URLhttps://en.wikipedia.org/?curid=14650105
Wikipedia Retrieval Date2026-10-21T22:41:10+00:00

Reviews

There are no reviews yet.

Be the first to review “Mephedrone”

Your email address will not be published. Required fields are marked *

Documentation

Download Certificates of Analysis